PMC:7461420 / 93482-93721
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T339 | 227-235 | Body_part | denotes | endosome | http://purl.org/sig/ont/fma/fma67180 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T437 | 97-101 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T438 | 159-174 | Disease | denotes | viral infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
| T439 | 165-174 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1045 | 7-16 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signaling |
| T1046 | 64-70 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T684 | 17-35 | Chemical | denotes | pathway inhibitors | http://purl.obolibrary.org/obo/CHEBI_76932 |
| T685 | 25-35 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T686 | 36-44 | Chemical | denotes | imatinib | http://purl.obolibrary.org/obo/CHEBI_45783 |
| T687 | 49-58 | Chemical | denotes | dasatinib | http://purl.obolibrary.org/obo/CHEBI_49375|http://purl.obolibrary.org/obo/CHEBI_70839 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T119 | 7-24 | http://purl.obolibrary.org/obo/GO_0007165 | denotes | signaling pathway |
| T120 | 7-16 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
| T121 | 159-174 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infection |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2856 | 84-92 | Species | denotes | MERS‐CoV | Tax:1335626 |
| 2857 | 97-105 | Species | denotes | SARS‐CoV | Tax:694009 |
| 2858 | 36-44 | Chemical | denotes | imatinib | MESH:D000068877 |
| 2859 | 49-58 | Chemical | denotes | dasatinib | MESH:D000069439 |
| 2860 | 109-117 | Chemical | denotes | Imatinib | MESH:D000068877 |
| 2861 | 159-174 | Disease | denotes | viral infection | MESH:D001102 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T830 | 0-108 | Sentence | denotes | Kinase signaling pathway inhibitors imatinib and dasatinib were active against both MERS‐CoV and SARS‐CoV‐1. |
| T831 | 109-236 | Sentence | denotes | Imatinib was reported to act at an early stage of viral infection by hampering the fusion of viral particles with the endosome. |
| T832 | 237-239 | Sentence | denotes | 53 |